Jin Medical International (ZJYL) Shares Outstanding (Weighted Average) (2023 - 2025)

Jin Medical International has disclosed Shares Outstanding (Weighted Average) across 3 years of filings, most recently posting $156.5 million for Q1 2025.

• Shares Outstanding (Weighted Average) for Q1 2025 came in at $156.5 million, changed 0.09% year-over-year; the trailing twelve-month figure through Mar 2025 was $156.5 million (changed 0.09% YoY), and the FY2021 annual result was $135.0 million, changed N/A from the prior year.
• Shares Outstanding (Weighted Average) came in at $156.5 million for Q1 2025 at Jin Medical International, roughly flat from $156.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $156.5 million in Q1 2025 to a low of $135.2 million in Q1 2023.
• The 3-year median for Shares Outstanding (Weighted Average) is $156.4 million (2024), against an average of $149.4 million.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 15.66% in 2024 and grew 0.09% in 2025, its largest moves.
• Jin Medical International's Shares Outstanding (Weighted Average) stood at $135.2 million in 2023, then gained by 15.66% to $156.4 million in 2024, then grew by 0.09% to $156.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $156.5 million (Q1 2025), $156.4 million (Q1 2024), and $135.2 million (Q1 2023), per Business Quant data.